Hualan Biological Bacterin Inc. (301207.SZ) SHZ
19.46
+0.07(+0.36%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
19.46
+0.07(+0.36%)
Currency In CNY
Address
No. 1, Westlands Road
Xinxiang, 453003
China
Phone
86 37 3355 9909
Sector
Healthcare
Industry
Biotechnology
Employees
748
First IPO Date
February 18, 2022
| Name | Title | Pay | Year Born |
| Ke Lu | Chief Financial Officer & Secretary | 0 | 1984 |
| Ruowen Pan | Executive Vice President & Director | 0 | 1968 |
| Wenjue An | GM & Director | 0 | 1989 |
Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China. Hualan Biological Bacterin Inc. was formerly a subsidiary of Hualan Biological Engineering Inc.